Collegium Pharmaceutical (COLL) Other financing activities (2014 - 2026)

Collegium Pharmaceutical has reported Other financing activities for 13 years, with the latest figure at $947000.0 in Q1 2026.

• On a quarterly basis, Other financing activities fell 38.98% year-over-year to $947000.0 in Q1 2026; TTM through Jun 2026 was $3.4 million, a 54.31% increase from a year earlier, with the FY2025 full-year figure at $4.3 million, down 58.23% from the prior year.
• Other financing activities was $947000.0 for Q1 2026 at Collegium Pharmaceutical, down from $985000.0 in the prior quarter.
• The five-year high for Other financing activities was $6.9 million in Q4 2022, with the low at $142000.0 in Q3 2022.
• Average Other financing activities over 5 years is $2.1 million, with a median of $1.4 million recorded in 2025.
• The sharpest annual moves came in 2024 and 2025: Other financing activities sank 94.66% in 2024, then jumped 863.09% in 2025.
• Over 5 years, Other financing activities stood at $6.9 million in 2022, then sank by 52.79% to $3.2 million in 2023, then tumbled by 94.66% to $173000.0 in 2024, then surged by 469.36% to $985000.0 in 2025, then declined by 3.86% to $947000.0 in 2026.
• The last three Other financing activities figures came in at $947000.0 (Q1 2026), $985000.0 (Q4 2025), and $1.4 million (Q3 2025), per Business Quant data.